Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Find the Excellence of Old style Expressive dance: Encountering the Effortlessness and Polish of Dance - 2Three arrested in Paris after attempted bomb attack outside Bank of America
- 37 Moves toward a Sound and Dynamic Way of life
- 4This Week In Space podcast: Episode 203 — China Rising
- 5Hamas delegation meets Egypt’s spy chief amid mutual ceasefire violation claims
- From Certificate to Dollars: College Majors with Extraordinary Monetary Prizes
- Germany raises prospect of military forces to secure Ukraine peace
- New COVID-19 variant 'Cicada' is spreading. What to know about BA.3.2.
- Step by step instructions to Contrast Lab Jewels and Regular Ones
- Navy-Marine Corps Relief Society provides emergency grants to families displaced by Iran war
- Vote in favor of the wide open action that revives your brain and soul!
- Trump administration launches new immigration crackdowns in New Orleans and Minneapolis. Here are all the cities it has targeted so far.
- Venezuelan President Maduro arrives in New York following U.S. capture: Full coverage
- Vote in favor of your Number one method for praising a birthday
